Ignite Creation Date:
2024-05-06 @ 7:40 PM
Last Modification Date:
2025-12-17 @ 12:49 AM
Study NCT ID:
NCT06090175
Status:
None
Last Update Posted:
2023-11-27 00:00:00
First Post:
2023-10-12 00:00:00
Brief Title:
The Effect of Using Projector Kaleidoscope and Matching Card on Children's Fear and Physiological Parameters
Sponsor:
Tarsus University
Organization:
Tarsus University
Study Overview
Official Title:
The Effect of Using Projector Kaleidoscope and Matching Card on Children's Fear and Physiological Parameters in 3-6 Year Old Children Who Are Administered Inhaler Medication
Status:
None
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Discovering ways to reduce/eliminate children's anxiety and fear regarding treatment practices will help children experience less fear and stress during these interventions. Examples of methods that can be used include watching cartoons, blowing up balloons, making bubbles, playing videos or games with virtual reality glasses, listening to music, using a caleidoscope, using distraction cards, clown shows, parents trying to divert attention, and playing toys.
Discovering ways to reduce/eliminate children's anxiety and fear regarding treatment practices will help children experience less fear and stress during these interventions.
This research was planned as a randomized controlled experimental type to determine the effect of using a projector collets-cope and matching card on children's fear and physiological parameters in 3-6-year-old children who were administered inhaler medication.
Place and Time the Research Was Conducted The research will be conducted in Tarsus State Hospital pediatric services. Pediatric 1 ward has 16 beds, the pediatric 2 ward has 20 beds, the infant 2 ward has 20 beds, the infant 1 ward has 16 beds and the pediatric surgery ward has 16 beds. Hospitalizations are made due to bronchitis, tonsillitis, measles, pneumonia, otitis, rheumatoid arthritis, nausea, vomiting, diarrhea, high fever, urinary tract infection, appendicitis, circumcision and scabies.
After obtaining written consent from the parent of the child to be treated with inhaler medication, the parent will be explained about the inhaler medication administration and what will be done during the procedure. Then the descriptive information form will be filled out. Children's physiological parameters (pulse, blood pressure, respiration, SPO2) will be measured before and after the procedure. The parent and nurse will evaluate the child's fear score before and after the procedure, which will be recorded in the follow-up form.
Inhaler drug administration is usually applied 3 times at 20-minute intervals in the clinic. While the first inhaler is being administered, the application will be done with the child sitting, choosing a mask suitable for his/her face. The child should be given an average of 10 minutes. After the inhaler medication is given through the mask for a period of time, the fear score will be evaluated simultaneously by the nurse and the parent.
Projector caleidoscope group: Approximately 10 minutes for the child. Inhaler medication will be given with a mask that lasts. Before starting the procedure, the child will be introduced to the projector caleidoscope. Before the procedure, this device, which looks like a toy, will be projected onto the wall to divert attention. The projection will continue throughout the inhaler medication administration process. Vital signs (pulse, blood pressure, SPo2, respiration) before and after the application, of the Child Fear Scale will be evaluated by the researcher and the parent and recorded in the intervention follow-up form by the researcher.
Matching card group: Approximately 10 minutes for the child. Inhaler medication will be given with a mask that lasts. The child will be allowed to play with the matching cards 2-3 minutes before starting the drug treatment and will then be encouraged to play throughout the procedure. Vital signs (pulse, blood pressure, SPo2, respiration) before and after the application, of the Child Fear Scale will be evaluated by the researcher and the parent and recorded in the intervention follow-up form by the researcher.
Control group: The child was given an average of 10 minutes. Inhaler medication will be provided with a mask that lasts. Nothing will be shown to the child during the application. Vital signs (pulse, blood pressure, SPo2, respiration) before and after the application, of the Child Fear Scale will be evaluated by the researcher and the parent and recorded by the researcher in the intervention follow-up form.
Data analysis The data obtained within the scope of the research will be evaluated using the Statistical Package For Social Science (SPSS) 26.0 package program. Number, percentage, mean and standard deviation will be used as descriptive statistical methods in the evaluation of the data. Normal distribution assumptions will be taken into account in the application of hypothesis tests.
Pearson chi-square test will be applied to determine whether the dependent variables are normally distributed according to the groups' characteristics. One Way ANOVA test will be used to compare quantitative continuous data between more than two independent groups. Repeated measurements within the group will be evaluated with the Repeated Measures test. The findings will be evaluated at a 95% confidence interval and a 5% significance level.
Discovering ways to reduce/eliminate children's anxiety and fear regarding treatment practices will help children experience less fear and stress during these interventions.
This research was planned as a randomized controlled experimental type to determine the effect of using a projector collets-cope and matching card on children's fear and physiological parameters in 3-6-year-old children who were administered inhaler medication.
Place and Time the Research Was Conducted The research will be conducted in Tarsus State Hospital pediatric services. Pediatric 1 ward has 16 beds, the pediatric 2 ward has 20 beds, the infant 2 ward has 20 beds, the infant 1 ward has 16 beds and the pediatric surgery ward has 16 beds. Hospitalizations are made due to bronchitis, tonsillitis, measles, pneumonia, otitis, rheumatoid arthritis, nausea, vomiting, diarrhea, high fever, urinary tract infection, appendicitis, circumcision and scabies.
After obtaining written consent from the parent of the child to be treated with inhaler medication, the parent will be explained about the inhaler medication administration and what will be done during the procedure. Then the descriptive information form will be filled out. Children's physiological parameters (pulse, blood pressure, respiration, SPO2) will be measured before and after the procedure. The parent and nurse will evaluate the child's fear score before and after the procedure, which will be recorded in the follow-up form.
Inhaler drug administration is usually applied 3 times at 20-minute intervals in the clinic. While the first inhaler is being administered, the application will be done with the child sitting, choosing a mask suitable for his/her face. The child should be given an average of 10 minutes. After the inhaler medication is given through the mask for a period of time, the fear score will be evaluated simultaneously by the nurse and the parent.
Projector caleidoscope group: Approximately 10 minutes for the child. Inhaler medication will be given with a mask that lasts. Before starting the procedure, the child will be introduced to the projector caleidoscope. Before the procedure, this device, which looks like a toy, will be projected onto the wall to divert attention. The projection will continue throughout the inhaler medication administration process. Vital signs (pulse, blood pressure, SPo2, respiration) before and after the application, of the Child Fear Scale will be evaluated by the researcher and the parent and recorded in the intervention follow-up form by the researcher.
Matching card group: Approximately 10 minutes for the child. Inhaler medication will be given with a mask that lasts. The child will be allowed to play with the matching cards 2-3 minutes before starting the drug treatment and will then be encouraged to play throughout the procedure. Vital signs (pulse, blood pressure, SPo2, respiration) before and after the application, of the Child Fear Scale will be evaluated by the researcher and the parent and recorded in the intervention follow-up form by the researcher.
Control group: The child was given an average of 10 minutes. Inhaler medication will be provided with a mask that lasts. Nothing will be shown to the child during the application. Vital signs (pulse, blood pressure, SPo2, respiration) before and after the application, of the Child Fear Scale will be evaluated by the researcher and the parent and recorded by the researcher in the intervention follow-up form.
Data analysis The data obtained within the scope of the research will be evaluated using the Statistical Package For Social Science (SPSS) 26.0 package program. Number, percentage, mean and standard deviation will be used as descriptive statistical methods in the evaluation of the data. Normal distribution assumptions will be taken into account in the application of hypothesis tests.
Pearson chi-square test will be applied to determine whether the dependent variables are normally distributed according to the groups' characteristics. One Way ANOVA test will be used to compare quantitative continuous data between more than two independent groups. Repeated measurements within the group will be evaluated with the Repeated Measures test. The findings will be evaluated at a 95% confidence interval and a 5% significance level.
Detailed Description:
Discovering ways to reduceeliminate childrens anxiety and fear regarding treatment practices will help children experience less fear and stress during these interventions Examples of methods that can be used include watching cartoons blowing up balloons making bubbles playing videos or games with virtual reality glasses listening to music using a caleidoscope using distraction cards clown shows parents trying to divert attention and playing toys
Discovering ways to reduceeliminate childrens anxiety and fear regarding treatment practices will help children experience less fear and stress during these interventions
This research was planned as a randomized controlled experimental type to determine the effect of using a projector collets-cope and matching card on childrens fear and physiological parameters in 3-6-year-old children who were administered inhaler medication
Place and Time the Research Was Conducted The research will be conducted in Tarsus State Hospital pediatric services Pediatric 1 ward has 16 beds the pediatric 2 ward has 20 beds the infant 2 ward has 20 beds the infant 1 ward has 16 beds and the pediatric surgery ward has 16 beds Hospitalizations are made due to bronchitis tonsillitis measles pneumonia otitis rheumatoid arthritis nausea vomiting diarrhea high fever urinary tract infection appendicitis circumcision and scabies
After obtaining written consent from the parent of the child to be treated with inhaler medication the parent will be explained about the inhaler medication administration and what will be done during the procedure Then the descriptive information form will be filled out Childrens physiological parameters pulse blood pressure respiration SPO2 will be measured before and after the procedure The parent and nurse will evaluate the childs fear score before and after the procedure which will be recorded in the follow-up form
Inhaler drug administration is usually applied 3 times at 20-minute intervals in the clinic While the first inhaler is being administered the application will be done with the child sitting choosing a mask suitable for hisher face The child should be given an average of 10 minutes After the inhaler medication is given through the mask for a period of time the fear score will be evaluated simultaneously by the nurse and the parent
Projector caleidoscope group Approximately 10 minutes for the child Inhaler medication will be given with a mask that lasts Before starting the procedure the child will be introduced to the projector caleidoscope Before the procedure this device which looks like a toy will be projected onto the wall to divert attention The projection will continue throughout the inhaler medication administration process Vital signs pulse blood pressure SPo2 respiration before and after the application of the Child Fear Scale will be evaluated by the researcher and the parent and recorded in the intervention follow-up form by the researcher
Matching card group Approximately 10 minutes for the child Inhaler medication will be given with a mask that lasts The child will be allowed to play with the matching cards 2-3 minutes before starting the drug treatment and will then be encouraged to play throughout the procedure Vital signs pulse blood pressure SPo2 respiration before and after the application of the Child Fear Scale will be evaluated by the researcher and the parent and recorded in the intervention follow-up form by the researcher
Control group The child was given an average of 10 minutes Inhaler medication will be provided with a mask that lasts Nothing will be shown to the child during the application Vital signs pulse blood pressure SPo2 respiration before and after the application of the Child Fear Scale will be evaluated by the researcher and the parent and recorded by the researcher in the intervention follow-up form
Data analysis The data obtained within the scope of the research will be evaluated using the Statistical Package For Social Science SPSS 260 package program Number percentage mean and standard deviation will be used as descriptive statistical methods in the evaluation of the data Normal distribution assumptions will be taken into account in the application of hypothesis tests
Pearson chi-square test will be applied to determine whether the dependent variables are normally distributed according to the groups characteristics One Way ANOVA test will be used to compare quantitative continuous data between more than two independent groups Repeated measurements within the group will be evaluated with the Repeated Measures test The findings will be evaluated at a 95 confidence interval and a 5 significance level
Discovering ways to reduceeliminate childrens anxiety and fear regarding treatment practices will help children experience less fear and stress during these interventions
This research was planned as a randomized controlled experimental type to determine the effect of using a projector collets-cope and matching card on childrens fear and physiological parameters in 3-6-year-old children who were administered inhaler medication
Place and Time the Research Was Conducted The research will be conducted in Tarsus State Hospital pediatric services Pediatric 1 ward has 16 beds the pediatric 2 ward has 20 beds the infant 2 ward has 20 beds the infant 1 ward has 16 beds and the pediatric surgery ward has 16 beds Hospitalizations are made due to bronchitis tonsillitis measles pneumonia otitis rheumatoid arthritis nausea vomiting diarrhea high fever urinary tract infection appendicitis circumcision and scabies
After obtaining written consent from the parent of the child to be treated with inhaler medication the parent will be explained about the inhaler medication administration and what will be done during the procedure Then the descriptive information form will be filled out Childrens physiological parameters pulse blood pressure respiration SPO2 will be measured before and after the procedure The parent and nurse will evaluate the childs fear score before and after the procedure which will be recorded in the follow-up form
Inhaler drug administration is usually applied 3 times at 20-minute intervals in the clinic While the first inhaler is being administered the application will be done with the child sitting choosing a mask suitable for hisher face The child should be given an average of 10 minutes After the inhaler medication is given through the mask for a period of time the fear score will be evaluated simultaneously by the nurse and the parent
Projector caleidoscope group Approximately 10 minutes for the child Inhaler medication will be given with a mask that lasts Before starting the procedure the child will be introduced to the projector caleidoscope Before the procedure this device which looks like a toy will be projected onto the wall to divert attention The projection will continue throughout the inhaler medication administration process Vital signs pulse blood pressure SPo2 respiration before and after the application of the Child Fear Scale will be evaluated by the researcher and the parent and recorded in the intervention follow-up form by the researcher
Matching card group Approximately 10 minutes for the child Inhaler medication will be given with a mask that lasts The child will be allowed to play with the matching cards 2-3 minutes before starting the drug treatment and will then be encouraged to play throughout the procedure Vital signs pulse blood pressure SPo2 respiration before and after the application of the Child Fear Scale will be evaluated by the researcher and the parent and recorded in the intervention follow-up form by the researcher
Control group The child was given an average of 10 minutes Inhaler medication will be provided with a mask that lasts Nothing will be shown to the child during the application Vital signs pulse blood pressure SPo2 respiration before and after the application of the Child Fear Scale will be evaluated by the researcher and the parent and recorded by the researcher in the intervention follow-up form
Data analysis The data obtained within the scope of the research will be evaluated using the Statistical Package For Social Science SPSS 260 package program Number percentage mean and standard deviation will be used as descriptive statistical methods in the evaluation of the data Normal distribution assumptions will be taken into account in the application of hypothesis tests
Pearson chi-square test will be applied to determine whether the dependent variables are normally distributed according to the groups characteristics One Way ANOVA test will be used to compare quantitative continuous data between more than two independent groups Repeated measurements within the group will be evaluated with the Repeated Measures test The findings will be evaluated at a 95 confidence interval and a 5 significance level
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None